Projection de l???incidence et de la mortalit?? par cancer urologique en France en 2012, Progr??s en Urologie, vol.23, issue.2, pp.57-65, 2013. ,
DOI : 10.1016/S1166-7087(13)70047-2
Robotassisted radical prostatectomy compared with open and laparoscopic approaches: a systematic review and meta-analysis, International journal of urology : official journal of the Japanese Urological Association, vol.2013, issue.203, pp.312-321 ,
Radical Prostatectomy or Watchful Waiting in Early Prostate Cancer, New England Journal of Medicine, vol.370, issue.10, pp.370932-942 ,
DOI : 10.1056/NEJMoa1311593
LONG-TERM BIOCHEMICAL DISEASE-FREE AND CANCER-SPECIFIC SURVIVAL FOLLOWING ANATOMIC RADICAL RETROPUBIC PROSTATECTOMY, Urologic Clinics of North America, vol.28, issue.3, pp.555-565, 2001. ,
DOI : 10.1016/S0094-0143(05)70163-4
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era, J Clin Oncol, issue.26, pp.274300-4305, 2009. ,
25-Year Prostate Cancer Control and Survival Outcomes: A 40-Year Radical Prostatectomy Single Institution Series, The Journal of Urology, vol.176, issue.2, pp.569-574, 2006. ,
DOI : 10.1016/j.juro.2006.03.094
Biochemical Recurrence Following Robot-Assisted Radical Prostatectomy: Analysis of 1384 Patients with a Median 5-year Follow-up, European Urology, vol.58, issue.6, pp.58838-846, 2010. ,
DOI : 10.1016/j.eururo.2010.09.010
Long-term Biochemical Recurrence Rates After Robot-assisted Radical Prostatectomy: Analysis of a Single-center Series of Patients With a Minimum Follow-up of 5 Years, Urology, vol.79, issue.1, pp.133-138 ,
DOI : 10.1016/j.urology.2011.08.045
Systematic Review and Meta-analysis of Studies Reporting Urinary Continence Recovery After Robot-assisted Radical Prostatectomy, European Urology, vol.62, issue.3, pp.62405-417 ,
DOI : 10.1016/j.eururo.2012.05.045
Systematic Review and Meta-analysis of Studies Reporting Potency Rates After Robot-assisted Radical Prostatectomy, European Urology, vol.62, issue.3, pp.62418-430 ,
DOI : 10.1016/j.eururo.2012.05.046
Intensitymodulated radiotherapy for the treatment of prostate cancer: a systematic review and economic evaluation, Health technology assessment, vol.14, issue.47, pp.1-108, 2010. ,
Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease?, Int J Radiat Oncol Biol Phys, issue.5, pp.791310-1317, 2011. ,
Dose Escalation for Prostate Cancer Radiotherapy: Predictors of Long-Term Biochemical Tumor Control and Distant Metastases???Free Survival Outcomes, European Urology, vol.60, issue.6, pp.601133-1139, 2011. ,
DOI : 10.1016/j.eururo.2011.08.029
Dose-Response in Radiotherapy for Localized Prostate Cancer: Results of the Dutch Multicenter Randomized Phase III Trial Comparing 68 Gy of Radiotherapy With 78 Gy, Journal of Clinical Oncology, vol.24, issue.13, pp.241990-1996, 2006. ,
DOI : 10.1200/JCO.2005.05.2530
Radiotherapy and Short-Term Androgen Deprivation for Localized Prostate Cancer, New England Journal of Medicine, vol.365, issue.2, pp.107-118, 2011. ,
DOI : 10.1056/NEJMoa1012348
Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial, The Lancet Oncology, vol.15, issue.4, pp.464-473, 2014. ,
DOI : 10.1016/S1470-2045(14)70040-3
The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer, Cancer, vol.53, issue.1, pp.55-60, 2008. ,
DOI : 10.1002/cncr.23139
Comparison of the 5-Year Outcome and Morbidity of Three-Dimensional Conformal Radiotherapy Versus Transperineal Permanent Iodine-125 Implantation for Early-Stage Prostatic Cancer, Journal of Clinical Oncology, vol.17, issue.2, pp.517-522, 1999. ,
DOI : 10.1200/JCO.1999.17.2.517
Analysis of second malignancies after modern radiotherapy versus prostatectomy for localized prostate cancer. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, pp.81-86, 2011. ,
Secondary Cancer After Radiotherapy for Prostate Cancer: Should We Be More Aware of the Risk?, European Urology, vol.52, issue.4, pp.973-982, 2007. ,
DOI : 10.1016/j.eururo.2007.07.002
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent???Update 2013, European Urology, vol.65, issue.1, pp.124-137 ,
DOI : 10.1016/j.eururo.2013.09.046
Multi-institutional analysis of long-term outcome for stages T1???T2 prostate cancer treated with permanent seed implantation, International Journal of Radiation Oncology*Biology*Physics, vol.67, issue.2, pp.327-333, 2007. ,
DOI : 10.1016/j.ijrobp.2006.08.056
10-year biochemical (prostate-specific antigen) control of prostate cancer with 125I brachytherapy, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.1, pp.31-40, 2001. ,
DOI : 10.1016/S0360-3016(01)01601-7
12-Year Outcomes Following Permanent Prostate Brachytherapy in Patients with Clinically Localized Prostate Cancer, The Journal of Urology, vol.179, issue.5, pp.20-24, 2008. ,
DOI : 10.1016/j.juro.2008.03.133
12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer Selecting patients for exclusive permanent implant prostate brachytherapy: the experience of the Paris Institut Curie/Cochin Hospital/Necker Hospital group on 809 patients, J Urol Cosset JM Int J Radiat Oncol Biol Phys, vol.173, issue.714, pp.1562-15661042, 2005. ,
Outcomes Following Iodine-125 Monotherapy for Localized Prostate Cancer: The Results of Leeds 10-Year Single-Center Brachytherapy Experience, International Journal of Radiation Oncology*Biology*Physics, vol.76, issue.1, pp.50-56, 2010. ,
DOI : 10.1016/j.ijrobp.2009.01.050
Functional outcomes and complications following radiation therapy for prostate cancer: a critical analysis of the literature Miller NL, Theodorescu D: Health-related quality of life after prostate brachytherapy, Eur Urol BJU Int, vol.2012, issue.944, pp.112-127487, 2004. ,
Urinary Symptom Flare in 712 125I Prostate Brachytherapy Patients: Long-Term Follow-Up, International Journal of Radiation Oncology*Biology*Physics, vol.75, issue.3, pp.75649-655, 2009. ,
DOI : 10.1016/j.ijrobp.2008.11.043
Temporal resolution of urinary morbidity following prostate brachytherapy, International Journal of Radiation Oncology*Biology*Physics, vol.47, issue.1, pp.121-128, 2000. ,
DOI : 10.1016/S0360-3016(99)00525-8
Long-Term Urinary, Sexual, and Rectal Morbidity in Patients Treated with Iodine-125 Prostate Brachytherapy Followed Up for a Minimum of 5 Years, Urology, vol.69, issue.2, pp.338-342, 2007. ,
DOI : 10.1016/j.urology.2006.10.001
Comparison of Tumor Control and Toxicity Outcomes of High-dose Intensity-modulated Radiotherapy and Brachytherapy for Patients With Favorable Risk Prostate Cancer, Urology, vol.77, issue.4, pp.986-990, 2011. ,
DOI : 10.1016/j.urology.2010.07.539
Second malignancies after prostate brachytherapy: Incidence of bladder and colorectal cancers in patients with 15 years of potential follow-up, International Journal of Radiation Oncology*Biology*Physics, vol.66, issue.3, pp.66669-673, 2006. ,
DOI : 10.1016/j.ijrobp.2006.05.016
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer, JAMA, vol.293, issue.17, pp.2095-2101, 2005. ,
DOI : 10.1001/jama.293.17.2095
Prostate-Cancer Mortality at 11 Years of Follow-up, New England Journal of Medicine, vol.366, issue.11, pp.366981-990, 2012. ,
DOI : 10.1056/NEJMoa1113135
Active Surveillance for Low-Risk Prostate Cancer Worldwide: The PRIAS Study, European Urology, vol.63, issue.4, pp.597-603, 2013. ,
DOI : 10.1016/j.eururo.2012.11.005
Clinical Results of Long-Term Follow-Up of a Large, Active Surveillance Cohort With Localized Prostate Cancer, Journal of Clinical Oncology, vol.28, issue.1, pp.126-131, 2010. ,
DOI : 10.1200/JCO.2009.24.2180
Outcome Following Active Surveillance of Men with Screen-detected Prostate Cancer. Results from the G??teborg Randomised Population-based Prostate Cancer Screening Trial, European Urology, vol.63, issue.1, pp.101-107, 2013. ,
DOI : 10.1016/j.eururo.2012.08.066
Radical Prostatectomy versus Observation for Localized Prostate Cancer, New England Journal of Medicine, vol.367, issue.3, pp.203-213 ,
DOI : 10.1056/NEJMoa1113162
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429335
Pathologic Findings in Radical Prostatectomy Specimens From Patients Eligible for Active Surveillance With Highly Selective Criteria: A Multicenter Study, Urology, vol.80, issue.3, pp.656-660 ,
DOI : 10.1016/j.urology.2012.04.051
Magnetic Resonance Imaging for Predicting Prostate Biopsy Findings in Patients Considered for Active Surveillance of Clinically Low Risk Prostate Cancer, The Journal of Urology, vol.188, issue.5, pp.1732-1738 ,
DOI : 10.1016/j.juro.2012.07.024
A Panel of TMPRSS2:ERG Fusion Transcript Markers for Urine-Based Prostate Cancer Detection with High Specificity and Sensitivity, European Urology, vol.59, issue.3, pp.59407-414, 2011. ,
DOI : 10.1016/j.eururo.2010.11.026
Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare Five-year retrospective, multi-institutional pooled analysis of cancer-related outcomes after cryosurgical ablation of the prostate, J Urol Urology, vol.2013, issue.573, pp.867-870518, 2001. ,
Ten-Year Biochemical Disease Control for Patients with Prostate Cancer Treated with Cryosurgery as Primary Therapy, Urology, vol.71, issue.3, pp.71515-518, 2008. ,
DOI : 10.1016/j.urology.2007.09.059
Comparison of biochemical failure definitions for predicting local cancer recurrence following cryoablation of the prostate Primary cryoablation nadir prostate specific antigen and biochemical failure, Prostate J Urol, vol.2012, issue.1823, pp.1802-1808931, 2009. ,
Primary and Salvage Cryotherapy for Prostate Cancer, Urologic Clinics of North America, vol.37, issue.1, pp.67-82471, 1954. ,
DOI : 10.1016/j.ucl.2009.11.007
Ultrasonic Lesions in the Mammalian Central Nervous System, Science, vol.122, issue.3168, pp.517-518, 1955. ,
DOI : 10.1126/science.122.3168.517
Effects of high-energy focused ultrasound on kidney tissue in the rat and the dog, European urology, vol.22, issue.2, pp.147-152, 1992. ,
In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327, Cancer Res, issue.22, pp.526353-6357, 1992. ,
Wholegland Ablation of Localized Prostate Cancer with High-intensity Focused Ultrasound: Oncologic Outcomes and Morbidity in 1002 Patients, Eur Urol, vol.2013, issue.13, pp.302-283800424 ,
Liver hemostasis using high-intensity focused ultrasound, Ultrasound in Medicine & Biology, vol.23, issue.9, pp.1413-1420, 1997. ,
DOI : 10.1016/S0301-5629(97)00143-9
Clinical and future applications of high intensity focused ultrasound in cancer, Cancer Treatment Reviews, vol.38, issue.5, pp.346-353 ,
DOI : 10.1016/j.ctrv.2011.08.004
TRANSRECTAL FOCUSED ULTRASOUND COMBINED WITH TRANSURETHRAL RESECTION OF THE PROSTATE FOR THE TREATMENT OF LOCALIZED PROSTATE CANCER: FEASIBILITY STUDY, The Journal of Urology, vol.171, issue.6, pp.2265-2267, 2004. ,
DOI : 10.1097/01.ju.0000124880.35944.58
Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience, Eur Urol, vol.29, issue.2, pp.174-183, 1996. ,
Transrectal High-Intensity Focused Ultrasound: Minimally Invasive Therapy of Localized Prostate Cancer, Journal of Endourology, vol.14, issue.6, pp.519-528, 2000. ,
DOI : 10.1089/end.2000.14.519
Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report, Urology, vol.59, issue.3, pp.394-398, 2002. ,
DOI : 10.1016/S0090-4295(01)01624-7
Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference High-intensity focused ultrasound for prostate cancer: comparative definitions of biochemical failure A: First analysis of the long-term results with transrectal HIFU in patients with localised prostate cancer, Int J Radiat Oncol Biol Phys BJU Int Eur Urol, vol.1565, issue.666, pp.965-9741058, 2006. ,
Fourteen-year oncological and functional outcomes of high-intensity focused ultrasound in localized prostate cancer, BJU International, vol.24, issue.3, pp.322-329, 2013. ,
DOI : 10.1111/j.1464-410X.2012.11715.x
Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: Eight-year experience, International Journal of Urology, vol.4, issue.11, pp.16881-886, 2009. ,
DOI : 10.1111/j.1442-2042.2009.02389.x
Improved Outcomes Owing to High-intensity Focused Ultrasound Devices Version-up for the Treatment of Patients with Localized Prostate Cancer Blana A: PSA nadir is a significant predictor of treatment failure after high-intensity focussed ultrasound (HIFU) treatment of localised prostate cancer, J Urol Eur Urol, vol.70, issue.533, pp.547-553, 2008. ,
Correlation of pretreatment clinical parameters and PSA nadir after high-intensity focused ultrasound (HIFU) for localised prostate cancer, World Journal of Urology, vol.104, issue.8, 2014. ,
DOI : 10.1007/s00345-014-1289-2
To what extent does the prostatespecific antigen nadir predict subsequent treatment failure after transrectal highintensity focused ultrasound therapy for presumed localized adenocarcinoma of the prostate? BJU international, pp.98537-539, 2006. ,
Seven years of experience with highintensity focused ultrasound for prostate cancer: advantages and limitations, Prostate, vol.2012, issue.13, pp.721399-1406 ,
Single-session primary high-intensity focused ultrasonography treatment for localized prostate cancer: biochemical outcomes using third generation-based technology, BJU Int, vol.2012, issue.8, pp.1101142-1148 ,
Multicentric Oncologic Outcomes of High-Intensity Focused Ultrasound for Localized Prostate Cancer in 803 Patients, European Urology, vol.58, issue.4, pp.559-566, 2010. ,
DOI : 10.1016/j.eururo.2010.06.037
Single application of high-intensity focused ultrasound as a first-line therapy for clinically localized prostate cancer: 5-year outcomes, BJU International, vol.180, issue.4, pp.1101702-1707 ,
DOI : 10.1111/j.1464-410X.2012.11375.x
Control of Prostate Cancer by Transrectal HIFU in 227 Patients, European Urology, vol.51, issue.2, pp.51381-387, 2007. ,
DOI : 10.1016/j.eururo.2006.04.012
URL : https://hal.archives-ouvertes.fr/hal-00397445
Evolution and Outcomes of 3 MHz High Intensity Focused Ultrasound Therapy for Localized Prostate Cancer During 15 Years, The Journal of Urology, vol.190, issue.2, pp.702-710 ,
DOI : 10.1016/j.juro.2013.02.010
Systematic Review of the Efficacy and Safety of High-Intensity Focussed Ultrasound for the Primary and Salvage Treatment of Prostate Cancer, European Urology, vol.58, issue.6, pp.58803-815, 2010. ,
DOI : 10.1016/j.eururo.2010.09.009
High-intensity focused ultrasound (HIFU) for definitive treatment of prostate cancer, BJU Int, vol.2012, issue.1109, pp.1228-1242 ,
Salvage Radiotherapy After High-Intensity Focussed Ultrasound for Recurrent Localised Prostate Cancer, European Urology, vol.58, issue.4, pp.567-573, 2010. ,
DOI : 10.1016/j.eururo.2010.06.003
Androgen-Deprivation Therapy in Prostate Cancer and Cardiovascular Risk: A Science Advisory From the American Heart Association, American Cancer Society, and American Urological Association: Endorsed by the American Society for Radiation Oncology, CA: A Cancer Journal for Clinicians, vol.60, issue.3, pp.60194-201, 2010. ,
DOI : 10.3322/caac.20061
Prostate cancer transrectal HIFU ablation: detection of local recurrences using T2-weighted and dynamic contrast-enhanced MRI, European Radiology, vol.65, issue.6, pp.48-55, 2010. ,
DOI : 10.1007/s00330-009-1520-5
URL : https://hal.archives-ouvertes.fr/hal-00539311
Role of imaging and biopsy to assess local recurrence after definitive treatment for prostate carcinoma (surgery, radiotherapy, cryotherapy, HIFU), World Journal of Urology, vol.190, issue.4, pp.29595-605, 2011. ,
DOI : 10.1007/s00345-011-0687-y
Systematic Review and Meta-analysis of Studies Reporting Oncologic Outcome After Robot-assisted Radical Prostatectomy, European Urology, vol.62, issue.3, pp.62382-404 ,
DOI : 10.1016/j.eururo.2012.05.047
Neoadjuvant hormonal therapy does not impact the treatment success of high-intensity focused ultrasound for the treatment of localized prostate cancer, World Journal of Urology, vol.17, issue.8, pp.29689-694, 2011. ,
DOI : 10.1007/s00345-010-0628-1
Treatment failure after primary and salvage therapy for prostate cancer, Cancer, vol.173, issue.2, pp.307-314, 2008. ,
DOI : 10.1002/cncr.23161
Salvage laparoscopic extraperitoneal radical prostatectomy after failed high-intensity focused ultrasound and radiotherapy for localized prostate cancer Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer, Urology World J Urol, vol.70, issue.245, pp.956-960585, 2006. ,
Traitement du cancer localis?? de la prostate avec l???appareil Ablatherm Imagerie Int??gr??e????: r??sultats carcinologiques et fonctionnels, Outcomes of HIFU for localised prostate cancer using the Ablatherm Integrate Imaging(R) device], pp.191-197, 2011. ,
DOI : 10.1016/j.purol.2010.07.005